Displaying drugs 1826 - 1850 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Eszopiclone | 388.808 C17H17ClN6O3 |  | A sedative-hypnotic used in the treatment of insomnia, improving both the latency phase and the maintenance phase of sleep. | Drugs causing inadvertant photosensitivity / Piperazines / Pyrazines / Pyridines |
| Estrone sulfate | 350.429 C18H22O5S |  | An estrogen used as monotherapy or in several combination hormone replacement products for managing menopause symptoms and hormone disorders. | Contraceptive Agents, Hormonal / Estrogens, Conjugated (USP) |
| Estrone | 270.3661 C18H22O2 |  | An estrogen used to treat perimenopausal and postmenopausal symptoms. | Natural and Semisynthetic Estrogens, Plain |
| Estriol | 288.3814 C18H24O3 |  | A weak estrogen used to treat vaginal dryness and estrogen deficiency conditions, such as vaginitis and vulvar itching. | Natural and Semisynthetic Estrogens, Plain |
| Estramustine phosphate | 520.38 C23H32Cl2NO6P |  | A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties. | Antineoplastic Agents, Alkylating / Antineoplastic Agents, Hormonal / Nitrogen Mustard Compounds |
| Estramustine | 440.403 C23H31Cl2NO3 |  | An antineoplastic agent used for the management of metastatic and/or progressive prostate cancer in palliative setting. | Alkylating Drugs / Antineoplastic Agents, Alkylating / Antineoplastic Agents, Hormonal / Nitrogen Mustard Compounds |
| Estradiol valerate | 356.4984 C23H32O3 |  | An estradiol prodrug used to treat some effects of menopause, hypoestrogenism, androgen dependant carcinoma of the prostate, and in combination products for endometriosis and contraception. | Estradiol Congeners / Estradiol, agonists / Estrenes / Estrogens |
| Estradiol dienanthate | 496.732 C32H48O4 |  | An estrogen used in some combined hormonal oral contraceptives. | BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP1A2 Inhibitors (weak) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Estradiol Congeners / Estranes / Estrenes / Fused-Ring Compounds / Gonadal Hormones / Gonadal Steroid Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / OATP1B1/SLCO1B1 Inhibitors / OCT1 inhibitors / OCT2 Inhibitors / Organic Anion Transporting Polypeptide 2B1 Inhibitors / P-glycoprotein substrates / Steroids / UGT1A1 Substrates |
| Estradiol cypionate | 396.5622 C26H36O3 |  | An estradiol prodrug used to treat vasomotor symptoms and hypoestrogenisms from hypogonadism. | Contraceptive Agents, Female / Contraceptive Agents, Hormonal / Estrogens |
| Estradiol benzoate | 376.488 C25H28O3 |  | An estrogen indicated in combination with progesterone for the treatment of irregular menstruation. | Contraceptive Agents, Hormonal |
| Estradiol acetate | 314.4186 C20H26O3 |  | An estrogen used to treat vasomotor symptoms and moderate to severe vulvar and vaginal atrophy from menopause. | Estrogens |
| Estradiol | 272.382 C18H24O2 |  | An estrogenic steroid used to treat vasomotor symptoms of vulvar and vaginal atrophy in menopause, hypoestrogenism, prevention of postmenopausal osteoporosis, treatment of breast cancer, and advanced androgen-dependent carcinoma of the prostate. | Androgens and Estrogens / Anti-Gonadotropin-Releasing Hormones / Antiandrogens and Estrogens / Intravaginal Contraceptives / Natural and Semisynthetic Estrogens, Plain / Progestogens and Estrogens, Sequential Preparations |
| Estetrol | 304.3808 C18H24O4 |  | An estrogen used in combination with drospirenone for oral contraception. | Estrogens |
| Esterified estrogens | Not Available |  | A female hormone used to treat conditions related to estrogen deficiency and moderate to severe vasomotor menopausal symptoms in women. | Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Estrogens / Thyroxine-binding globulin inducers |
| Estazolam | 294.738 C16H11ClN4 |  | A benzodiazepine used for the short-term management of insomnia. | Anti-Anxiety Agents / Anticonvulsants / Benzodiazepines and benzodiazepine derivatives / Drugs causing inadvertant photosensitivity / GABA Modulators |
| Esomeprazole | 345.416 C17H19N3O3S |  | A proton pump inhibitor used to treat GERD, reduce the risk of NSAID associated gastric ulcers, eradicate H. pylori, and to treat conditions causing gastric acid hypersecretion. | Propionates |
| Esmolol | 295.374 C16H25NO4 |  | A cardioselective beta-adrenergic blocker used for the short-term control of ventricular rate and heart rate in various types of tachycardia, including perioperative tachycardia and hypertension. | Beta Blocking Agents, Selective |
| Eslicarbazepine acetate | 296.326 C17H16N2O3 |  | An anticonvulsant agent used as an adjunct to treat partial-onset seizures in patients with inadequate clinical response to conventional antiepileptic therapy. | Carboxamide Derivatives |
| Eslicarbazepine | 254.2839 C15H14N2O2 |  | An antiepileptic indicated as a monotherapy or adjunct therapy in the treatment of epilepsy. | Carboxamide Derivatives |
| Esketamine | 237.73 C13H16ClNO |  | A NMDA receptor antagonist used for treatment-resistant depression. | Agents producing tachycardia / Anesthetics / Anesthetics, General / Antidepressive Agents / Antidepressive Agents Indicated for Depression / Central Nervous System Agents / Central Nervous System Depressants / Cyclohexanes / Cycloparaffins / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (weak) / Cytochrome P-450 CYP2B6 Substrates / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / Miscellaneous Antidepressants / Nervous System / NMDA Receptor Antagonists / Non-Competitive N-Methyl D-Aspartate (NMDA) Receptor Antagonists / Psychoanaleptics / Psychotropic Drugs |
| Esculin | 340.284 C15H16O9 |  | As medication, esculin is sometimes used as a vasoprotective agent. Esculin is also used in a microbiology laboratory to aid in the identification of bacterial species (especially Enterococci and Listeria),... | Coumarins / Glucosides |
| Escitalopram | 324.3919 C20H21FN2O |  | A selective serotonin re-uptake inhibitor used in the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), and other select psychiatric disorders such as obsessive-compulsive disorder (OCD). | Antidepressive Agents Indicated for Depression / Antidepressive Agents, Second-Generation / Benzofurans / Drugs causing inadvertant photosensitivity / Nitriles / Propylamines / Selective Serotonin Reuptake Inhibitors |
| Erythromycin | 733.9268 C37H67NO13 |  | A macrolide antibiotic used to treat and prevent a variety of bacterial infections. | Antiinfectives for Treatment of Acne |
| Erythrityl tetranitrate | 302.11 C4H6N4O12 |  | For the prevention of angina. | Organic Nitrates / Vasodilating Agents |
| Ertugliflozin | 436.89 C22H25ClO7 |  | An SGLT2 inhibitor used to treat type 2 diabetes mellitus alone or in combination with other antidiabetic drugs. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 2 Inhibitors |
Displaying drugs 1826 - 1850 of 2774 in total